AA
Ajay Avinash Nadkarni
About Ajay Avinash Nadkarni
Data last updated:
Ajay Avinash Nadkarni is a Company Secretary at Glaxosmithkline Pharmaceuticals Limited (since 2001), Director at Gsk India Global Services Private Limited (since 2020) and Director at Biddle Sawyer Limited (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹5,448 Cr; the largest is Glaxosmithkline Pharmaceuticals Limited at ₹3,895 Cr (FY 2025). Earlier, Ajay Avinash Nadkarni was a Nominee Director at Glaxosmithkline Asia Private Limited (2018–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 01 Nov 2001 | 1924 | ₹3,895 Cr (FY 2025) | Active | |
| Director | 23 Jun 2020 | 2020 | ₹1,466 Cr (FY 2025) | Active | |
| Director | 01 Dec 2022 | 1948 | ₹54.40 Cr (FY 2026) | Active | |
| Director | 03 Jan 2011 | 2000 | ₹31.87 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 28 Jul 2018 | 1995 | ₹2,362 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ajay Avinash Nadkarni
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajay Avinash Nadkarni
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajay Avinash Nadkarni
Ajay Avinash Nadkarni currently holds 4 directorships: Glaxosmithkline Pharmaceuticals Limited (Company Secretary, since 01 Nov 2001, revenue ₹3,895 Cr (FY 2025)); Gsk India Global Services Private Limited (Director, since 23 Jun 2020, revenue ₹1,466 Cr (FY 2025)); Biddle Sawyer Limited (Director, since 01 Dec 2022, revenue ₹54.40 Cr (FY 2026)); Gsk Pharma India Private Limited (Director, since 03 Jan 2011, revenue ₹31.87 Cr (FY 2025)).
Ajay Avinash Nadkarni was first appointed on 01 Nov 2001 as Company Secretary at Glaxosmithkline Pharmaceuticals Limited. The most recent appointment on record is 01 Dec 2022 at Biddle Sawyer Limited.
The 4 current companies of Ajay Avinash Nadkarni that report revenue have a combined latest revenue of ₹5,448 Cr: Glaxosmithkline Pharmaceuticals Limited ₹3,895 Cr (FY 2025); Gsk India Global Services Private Limited ₹1,466 Cr (FY 2025); Biddle Sawyer Limited ₹54.40 Cr (FY 2026); Gsk Pharma India Private Limited ₹31.87 Cr (FY 2025).
Ajay Avinash Nadkarni held 1 earlier board appointment: Glaxosmithkline Asia Private Limited (Nominee Director, 28 Jul 2018 to 01 Sep 2020).
The current boards of Ajay Avinash Nadkarni's companies include Anup Wadhawan (Glaxosmithkline Pharmaceuticals Limited), Bhushan Arun Akshikar (Glaxosmithkline Pharmaceuticals Limited), Manu Anand (Glaxosmithkline Pharmaceuticals Limited), Renu Sud Karnad (Glaxosmithkline Pharmaceuticals Limited), Ronojit Biswas (Glaxosmithkline Pharmaceuticals Limited), Ronojit Biswas (Glaxosmithkline Pharmaceuticals Limited), among others.